Garcia-Contreras D

No ORCID on file · 1 paper in corpus · active 2020
2020
Vaginal Suppositories Containing SHetA2 to Treat Cervical Dysplasia: Pharmacokinetics of Daily Doses and Preliminary Safety Profile.
Journal of pharmaceutical sciences ·doi:10.1016/j.xphs.2020.02.016

SHetA2 is a new drug with potential to treat cervical dysplasia, but only 0.02% of the dose is absorbed into the cervix after oral administration. By contrast, 23.9% of the dose is absorbed into the cervix after vaginal administration. This…